QQQQ
Lv5
1038 积分
2022-05-06 加入
-
Evaluation of HRCT-Derived Quantitative Lung Fibrosis (QLF) Scores in an 8-Week Phase 2a Study for Treatment of Idiopathic Pulmonary Fibrosis (IPF) Using BG00011
6小时前
待确认
-
A novel hepatitis B virus capsid assembly modulator QL-007 inhibits HBV replication and infection through altering capsid assembly
1个月前
已完结
-
Systematic review with network meta-analysis: sustained hepatitis B surface antigen clearance after pegylated interferon cessation
1个月前
已完结
-
Migraine
1个月前
已完结
-
Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis
1个月前
已完结
-
Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis
1个月前
已完结
-
Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases
2个月前
已完结
-
Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial
2个月前
已关闭
-
Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial
2个月前
已完结
-
Mechanism of hepatobiliary toxicity of the LPA1 antagonist BMS-986020 developed to treat idiopathic pulmonary fibrosis: Contrasts with BMS-986234 and BMS-986278
2个月前
已完结